UBS O'Connor’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-238,623
Closed -$2.38M 493
2022
Q3
$2.38M Sell
238,623
-23,888
-9% -$237K 0.03% 531
2022
Q2
$2.62M Buy
+262,511
New +$2.59M 0.03% 517
2022
Q1
Sell
-257,885
Closed -$2.53M 351
2021
Q4
$2.53M Buy
+257,885
New +$2.52M 0.02% 485

Other funds holding PEPL

UBS O'Connor's PEPL Position: Q4 2022 in Review

UBS O'Connor sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.38M sold.

UBS O'Connor first reported a position in PEPL in Q4 2021 and held it in 3 quarters. The position peaked at $2.62M in Q2 2022. 43 funds tracked by Wall St. Rank hold PEPL as of Q4 2022.

  • UBS O'Connor reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 238,623 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q4 2022, an estimated $2.38M.
  • UBS O'Connor first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
  • UBS O'Connor's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $2.62M in Q2 2022.
  • 43 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.